Jupiter Life Line Hospitals Ltd.NSE: JLHL

JLHL: Q1 FY2025 delivered robust growth, margin expansion, and continued progress on hospital expansion

· Issued by Jupiter Life Line Hospitals Ltd.

Q1 FY2025 saw 18.2% revenue growth and 20.9% EBITDA growth year-over-year, with strong occupancy gains in Pune and Indore. Expansion is on track, with new beds added and further projects underway, while margins are expected to reach 25% as hospitals mature.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.